News stories about St Jude Medical (NYSE:STJ) have trended positive on Wednesday, according to Accern Sentiment. Accern identifies positive and negative press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. St Jude Medical earned a coverage optimism score of 0.35 on Accern’s scale. Accern also gave press coverage about the medical technology company an impact score of 46.2324484627825 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

The company has a quick ratio of 1.31, a current ratio of 1.93 and a debt-to-equity ratio of 1.20.

COPYRIGHT VIOLATION WARNING: This article was posted by Marea Informative and is the property of of Marea Informative. If you are reading this article on another domain, it was stolen and republished in violation of U.S. & international copyright and trademark laws. The original version of this article can be accessed at https://www.mareainformativa.com/2018/03/14/positive-press-coverage-somewhat-unlikely-to-affect-st-jude-medical-stj-share-price-updated-updated-updated.html.

About St Jude Medical

St. Jude Medical, Inc is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders.

Insider Buying and Selling by Quarter for St Jude Medical (NYSE:STJ)

Receive News & Ratings for St Jude Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for St Jude Medical and related companies with MarketBeat.com's FREE daily email newsletter.